SCHEMBL6918

SCHEMBL6918

[CH]1[CH]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2992458 0.79
SCHEMBL4130638 0.74
SCHEMBL7697307 0.74
SCHEMBL25653 0.68
SCHEMBL23908695 0.67
SCHEMBL3788025 0.63
SCHEMBL395630 0.63
SCHEMBL2326 0.60
SCHEMBL2088 0.60
SCHEMBL1112757 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3321 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117043140-A Substituted pyrrolidin-2-ones, salts thereof and their use as herbicidal active substances 拜耳公司 2023-11-10 CN claimed
WO-2023192782-A2 SMALL MOLECULE INHIBITORS OF LANOSTEROL SYNTHASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-10-05 WO claimed
CN-111954673-B New penam derivatives or salts thereof, pharmaceutical compositions and uses thereof 富士胶片株式会社 2023-09-05 CN claimed
US-20230190883-A1 STABLE PEPTIDES HAVING RENALASE AGONIST ACTIVITY PERSONAL THERAPEUTICS, LLC 2023-06-22 US claimed
CN-116157140-A Stable peptides with renal enzymatic agent activity 贝索制药有限责任公司 2023-05-23 CN claimed
CN-111032656-B Heterocyclic compound kinase inhibitor and pharmaceutical composition and application thereof 捷思英达医药技术(上海)有限公司 2022-12-02 CN claimed
CN-111868096-B Reactive alginic acid derivatives 持田制药株式会社 2022-06-17 CN claimed
US-11242334-B2 Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof JS INNOPHARM (SHANGHAI) LTD. (CN) 2022-02-08 US claimed
EP-2847149-B1 OLIGOMERISATION OF OLEFINIC COMPOUNDS WITH REDUCED POLYMER FORMATION SASOL TECH PTY LTD (ZA) 2022-01-12 EP claimed
US-11083710-B2 PSMA binding ligand-linker conjugates and methods for using PURDUE RESEARCH FOUNDATION (US) 2021-08-10 US claimed
WO-1995013257-A1 2,6-DIFLUOROBENZENES AND THEIR USE IN LIQUID-CRYSTAL MIXTURES MERCK PATENT GMBH (DE) 1995-05-18 WO claimed
WO-1995011890-A1 6-FLUOROBENZOTHIAZOLES AND THEIR USE IN LIQUID CRYSTAL MIXTURES MERCK PATENT GMBH (DE) 1995-05-04 WO claimed
WO-1995011214-A1 4-TRIFLUOROMETHYLBENZENES AND THEIR USE IN LIQUID-CRYSTAL MIXTURES MERCK PATENT GMBH (DE) 1995-04-27 WO claimed
WO-1995010495-A1 2,3,4,5-TETRAFLUOROBENZENES AND THEIR USE IN LIQUID CRYSTAL MIXTURES MERCK PATENT GMBH (DE) 1995-04-20 WO claimed
WO-1995009829-A1 2,4-DIFLUOROBENZENES AND THEIR USE IN LIQUID CRYSTAL MIXTURES MERCK PATENT GMBH (DE) 1995-04-13 WO claimed
WO-1995009827-A1 3,4-DIFLUOROBENZENES AND THEIR USE IN LIQUID-CRYSTAL MIXTURES MERCK PATENT GMBH (DE) 1995-04-13 WO claimed
EP-0445013-B1 C-cycloalkyl-alkylamines, process for their preparation, their use as therapeutic agents and intermediates for their synthesis JOUVEINAL SA (FR) 1994-06-08 EP claimed
WO-1993000359-A1 MODIFIED PEPTIDES TRANSPORTABLE INTO THE CENTRAL NERVOUS SYSTEM THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-01-07 WO claimed
US-5089639-A N-CYCLOALKYLALKYLAMINES, PROCESS FOR THEIR PREPARATION, THEIR USE AS A MEDICAMENT AND THEIR SYNTHESIS INTERMEDIATES JOUVEINAL S.A. (FR) 1992-02-18 US claimed
US-5034419-A Psychological disorders or gastrointestinal disorders L'OREAL (FR) 1991-07-23 US claimed